Literature DB >> 27085560

Bladder Paraganglioma: Clinicopathology and Magnetic Resonance Imaging Study of Five Patients.

Jiuping Liang1, Hengguo Li1, Likun Gao2, Liang Yin3, Lei Yin4, Jiawen Zhang5.   

Abstract

PURPOSE: To investigate the clinicopathology and magnetic resonance imaging (MRI) features of bladder paraganglioma, an extremely rare clinical entity.
MATERIALS AND METHODS: Five patients with bladder paraganglioma (3 males and 2 females, 27-52 years old) were retrospectively reviewed. All cases underwent baseline MRI and contrast-enhanced scans, and three cases underwent diffusion weighted imaging (DWI) and cystoscopy. Cases were immunohistochemically examined with neuroendocrine markers (chromogranin and synaptophysin) and Ki-67, and histology was reviewed by a pathologist.
RESULTS: Three cases exhibited painless gross hematuria, including one case with hypertension, whereas two cases were asymptomatic. One of the three patients who underwent cystoscopy was negative. The tumors were round (n = 1) or oval (n = 4) and located in the anterior wall (n = 1), posterior wall (n = 1), lateral wall (n = 2) or trigone (n = 1). All tumors were located in the submucosal or lamina propria. Four cases presented with well-circumscribed margins, whereas one case was poorly circumscribed. All tumors exhibited slight hyperintensity on T1-weighted images (T1WI) and hyperintensity with "salt and pepper" appearance on T2-weighted images (T2WI). DWI indicated strong hyperintensity, and all cases exhibited conspicuous enhancement after intravenous gadobenate dimeglumine (Gd-DTPA) injection. Pathological evaluation confirmed paraganglioma.
CONCLUSION: MRI plays an important role in the preoperative diagnosis of bladder paraganglioma. This rare condition has a characteristic round or oval appearance, located in the submucosal area, with slight hyperintensity on T1WI and hyperintensity with "salt and pepper" appearance on T2WI. DWI indicated strong hyperintensity and conspicuous enhancement on contrast-enhanced scans.

Entities:  

Mesh:

Year:  2016        PMID: 27085560

Source DB:  PubMed          Journal:  Urol J        ISSN: 1735-1308            Impact factor:   1.510


  8 in total

1.  Genitourinary paraganglioma: Demographic, pathologic, and clinical characteristics in the surveillance, epidemiology, and end results database (2000-2012).

Authors:  Stephanie Purnell; Abhinav Sidana; Mahir Maruf; Campbell Grant; Piyush K Agarwal
Journal:  Urol Oncol       Date:  2017-03-18       Impact factor: 3.498

Review 2.  Magnetic resonance imaging of bladder pheochromocytomas: a review.

Authors:  Yanni Zulia; DheerajReddy Gopireddy; Mayur K Virarkar; Ajaykumar C Morani; Padma Adimula; Sindhu Kumar; Priya Bhosale; Chandana Lall
Journal:  Abdom Radiol (NY)       Date:  2022-03-28

Review 3.  Bladder paragangliomas: a pictorial review.

Authors:  Samuel J Withey; Dimitra Christodoulou; Davide Prezzi; Giles Rottenberg; Cherry Sit; Fahim Ul-Hassan; Paul Carroll; Anand Velusamy; Louise Izatt; Rajesh Nair; Audrey E T Jacques
Journal:  Abdom Radiol (NY)       Date:  2022-02-14

4.  Nonfunctional bladder paraganglioma misdiagnosed as hemangioma: A case report.

Authors:  Jiao Chen; Han-Feng Yang
Journal:  World J Clin Cases       Date:  2022-05-26       Impact factor: 1.534

5.  Urology pertinent neuroendocrine tumors: focusing on renal pelvis, bladder, prostate located sympathetic functional paragangliomas.

Authors:  C Alberti
Journal:  G Chir       Date:  2016 Mar-Apr

6.  Bladder Paraganglioma: Three Cases Report and Literature Review.

Authors:  Yaoji Yuan; Zhengming Su; Rui Zhu; Xiezhao Li; Guibin Xu
Journal:  Int Med Case Rep J       Date:  2021-11-12

7.  Bladder paraganglioma: CT and MR imaging characteristics in 16 patients.

Authors:  Jing Zhang; Xu Bai; Jing Yuan; Xiaojing Zhang; Wei Xu; Huiyi Ye; Haiyi Wang
Journal:  Radiol Oncol       Date:  2021-12-30       Impact factor: 2.991

8.  Differentiating Nonfunctional Paraganglioma of the Bladder from Urothelial Carcinoma of the Bladder: Pitfalls and Breakthroughs.

Authors:  Musa Male; Tao Ye; Jin Tao; Zhi-Qiang Chen; Ejun Peng
Journal:  Biomed Res Int       Date:  2019-11-06       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.